To further investigate the effects of EP300 inactivation in driving the invasive phenotype we undertook phenotypic studies and found that both genetic and pharmacological inhibition of EP300 increased melanoma cell survival and mediated resistance of melanoma cells to BRAFi therapy, hypoxia and UV irradiation. The gene discussed is EP300; the disease is melanoma.